Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Jewell

Showing results (241-250 of 244) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 244 results.
Nature Biomedical Engineering|November 29, 2025
mRNA engineering of allogeneic mesenchymal stem cells enables coordinated delivery of T cell engagers and immunotherapeutic cuesC Andrew Stewart, Shaji Daniel, Elizabeth J Curvino, et al.
Science Immunology|January 19, 2024
CD4<sup>+</sup> T cell immunity against cutaneous melanoma encompasses multifaceted MHC II-dependent responsesEmma G Bawden, Teagan Wagner, Jan Schröder, et al.
Nature Biotechnology|January 15, 2020
Peptide-TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigensGeoffrey M Lynn, Christine Sedlik, Faezzah Baharom, et al.
Nature Medicine|January 9, 2026
BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trialRenee R Fedak, Rachel N Ruggerie, Yufei Shan, et al.
Pageof 25

Showing results (241-250 of 244) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 244 results.
Nature Biomedical Engineering|November 29, 2025
mRNA engineering of allogeneic mesenchymal stem cells enables coordinated delivery of T cell engagers and immunotherapeutic cuesC Andrew Stewart, Shaji Daniel, Elizabeth J Curvino, et al.
Science Immunology|January 19, 2024
CD4<sup>+</sup> T cell immunity against cutaneous melanoma encompasses multifaceted MHC II-dependent responsesEmma G Bawden, Teagan Wagner, Jan Schröder, et al.
Nature Biotechnology|January 15, 2020
Peptide-TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigensGeoffrey M Lynn, Christine Sedlik, Faezzah Baharom, et al.
Nature Medicine|January 9, 2026
BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trialRenee R Fedak, Rachel N Ruggerie, Yufei Shan, et al.
Pageof 25